ZA9811180B - A method for the prevention and treatment of stunned myacardium - Google Patents
A method for the prevention and treatment of stunned myacardiumInfo
- Publication number
- ZA9811180B ZA9811180B ZA9811180A ZA9811180A ZA9811180B ZA 9811180 B ZA9811180 B ZA 9811180B ZA 9811180 A ZA9811180 A ZA 9811180A ZA 9811180 A ZA9811180 A ZA 9811180A ZA 9811180 B ZA9811180 B ZA 9811180B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- treatment
- myacardium
- stunned
- phospholamban
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Soil Working Implements (AREA)
- Nonmetallic Welding Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Road Signs Or Road Markings (AREA)
- Processing Of Meat And Fish (AREA)
- Fertilizers (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99014697A | 1997-12-12 | 1997-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9811180B true ZA9811180B (en) | 1999-06-09 |
Family
ID=25535825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9811180A ZA9811180B (en) | 1997-12-12 | 1998-12-07 | A method for the prevention and treatment of stunned myacardium |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5968959A (xx) |
| EP (1) | EP1039884B1 (xx) |
| JP (1) | JP2002508314A (xx) |
| AT (1) | ATE224187T1 (xx) |
| AU (1) | AU1565599A (xx) |
| BR (1) | BR9813549A (xx) |
| CA (1) | CA2311932A1 (xx) |
| DE (1) | DE69808131T2 (xx) |
| DK (1) | DK1039884T3 (xx) |
| ES (1) | ES2184341T3 (xx) |
| PT (1) | PT1039884E (xx) |
| WO (1) | WO1999030696A1 (xx) |
| ZA (1) | ZA9811180B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19839499A1 (de) * | 1998-08-29 | 2000-03-02 | Merck Patent Gmbh | 2-Oxo-2H-chinolinderivate |
| CA2349758A1 (en) * | 1998-11-02 | 2000-05-11 | The Regents Of The University Of California | A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| EP1728516A1 (en) * | 1998-11-02 | 2006-12-06 | The Regents of the University of California | A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
| JP2002062296A (ja) * | 2000-08-22 | 2002-02-28 | Yamaguchi Technology Licensing Organization Ltd | 心不全治療薬のスクリーニング方法 |
| DE60137778D1 (de) | 2000-09-11 | 2009-04-09 | Univ California | Dominant-negativer PLB Mutant zur Behandlung der Herzerkrankungen |
| US7183313B2 (en) * | 2002-08-23 | 2007-02-27 | University Of Connecticut | Keto cannabinoids with therapeutic indications |
| WO2005023292A1 (en) * | 2003-09-03 | 2005-03-17 | The General Hospital Corporation | Methods of treating restenosis |
| AR055041A1 (es) * | 2005-03-23 | 2007-08-01 | Merck Frosst Canada Ltd | Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas. |
| WO2007022946A1 (de) | 2005-08-21 | 2007-03-01 | Abbott Gmbh & Co. Kg | Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| FR2970964B1 (fr) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr |
| US9334256B2 (en) * | 2011-06-15 | 2016-05-10 | Nono Inc. | Agents and methods for treating ischemic and other diseases |
| WO2016032569A1 (en) * | 2014-08-29 | 2016-03-03 | Celladon Corporation | Quinolines and their use for treating endoplasmic reticulum stress-caused diseases |
| US20200347038A1 (en) | 2014-08-29 | 2020-11-05 | Russell Dahl | Quinolines that modulate serca and their use for treating disease |
| US11730729B2 (en) | 2020-07-20 | 2023-08-22 | Neurodon Corporation | Quinolines that modulate SERCA and their use for treating disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3259635A (en) * | 1962-07-26 | 1966-07-05 | Cassella Farbwerke Mainkur Ag | 7-hydroxy coumarin derivative |
| US3515721A (en) * | 1967-06-26 | 1970-06-02 | Cassella Farbwerke Mainkur Ag | 3-tertiary-aminoethyl-4-methyl or phenyl-7-ethoxycarbonylmethoxy - halo or mononitro coumarins and congeners |
| IT1088554B (it) * | 1977-11-17 | 1985-06-10 | F I D I A Spa | Procedimento sellettivo per la preparazione di derivati della 7-indrossi cumarina |
| IT1160365B (it) * | 1978-12-19 | 1987-03-11 | F I D I A Spa | Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3-(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossicumarina cloridrato preparato allo stato puro mediante procedimento selettivo, con particolare riguardo alla sua azione antiaritmica |
| EP1001774B1 (en) * | 1997-06-25 | 2004-09-15 | Orion Corporation | Use of phospholamban inhibitors for increasing coronary flow |
-
1998
- 1998-11-10 US US09/188,707 patent/US5968959A/en not_active Expired - Fee Related
- 1998-12-07 ZA ZA9811180A patent/ZA9811180B/xx unknown
- 1998-12-11 WO PCT/FI1998/000976 patent/WO1999030696A1/en not_active Ceased
- 1998-12-11 DK DK98959929T patent/DK1039884T3/da active
- 1998-12-11 AU AU15655/99A patent/AU1565599A/en not_active Abandoned
- 1998-12-11 CA CA002311932A patent/CA2311932A1/en not_active Abandoned
- 1998-12-11 EP EP98959929A patent/EP1039884B1/en not_active Expired - Lifetime
- 1998-12-11 JP JP2000538679A patent/JP2002508314A/ja active Pending
- 1998-12-11 PT PT98959929T patent/PT1039884E/pt unknown
- 1998-12-11 AT AT98959929T patent/ATE224187T1/de not_active IP Right Cessation
- 1998-12-11 ES ES98959929T patent/ES2184341T3/es not_active Expired - Lifetime
- 1998-12-11 DE DE69808131T patent/DE69808131T2/de not_active Expired - Fee Related
- 1998-12-11 BR BR9813549-0A patent/BR9813549A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2184341T3 (es) | 2003-04-01 |
| BR9813549A (pt) | 2000-10-10 |
| DK1039884T3 (da) | 2002-12-09 |
| US5968959A (en) | 1999-10-19 |
| JP2002508314A (ja) | 2002-03-19 |
| ATE224187T1 (de) | 2002-10-15 |
| WO1999030696A1 (en) | 1999-06-24 |
| DE69808131D1 (de) | 2002-10-24 |
| EP1039884B1 (en) | 2002-09-18 |
| PT1039884E (pt) | 2003-01-31 |
| CA2311932A1 (en) | 1999-06-24 |
| EP1039884A1 (en) | 2000-10-04 |
| DE69808131T2 (de) | 2003-06-05 |
| AU1565599A (en) | 1999-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9811180B (en) | A method for the prevention and treatment of stunned myacardium | |
| DE60213386D1 (de) | Geldanamycinderivate zur krebsbehandlung | |
| PT880350E (pt) | Tratamento de esclerose multipla | |
| WO1999046279A3 (en) | INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE | |
| NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
| GR3023537T3 (en) | Inhibition of thrombin. | |
| HU9401258D0 (en) | Treatment of acne or of pseudofolliculitis barbae | |
| DE59606784D1 (de) | Verwendung von boswelliasäure und ihren derivaten zur hemmung der normalen und gesteigerten leukozytenelastase- oder plasminaktivität | |
| DK85193D0 (da) | Suppression of inhibitors | |
| BG105875A (en) | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy | |
| LV12353A (lv) | Kruts veza profilakses metodes | |
| ID29187A (id) | Terapi kombinasi alfa internferon-ribavirin untuk memusnahkan hcv-rna yang dapat ditemukan pada pasien-pasien yang mengalami infeksi hepatitis c kronis | |
| DE69725879D1 (de) | VERWENDUNG VON p-AMINOPHENOLDERIVATEN ZUR HERSTELLUNG VON PHARMAZEUTISCHEN ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN | |
| DE60030107D1 (de) | Vitamin-d derivate zur behandlung des systemischen lupus erythematodes | |
| DE69924979D1 (de) | Behandlung von chronischen schmerzen | |
| CZ223199A3 (cs) | Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí | |
| AU2255201A (en) | Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold | |
| WO1997026880A3 (en) | Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients | |
| NO984196L (no) | FremgangsmÕte for behandling av stoffmisbruk | |
| MY118982A (en) | Method of reducing tissue damage associated with ischemia | |
| MX9701528A (es) | Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer. | |
| ATE312606T1 (de) | Verwendung eines imidazolderivats zur behandlung oder verhütung von hypotension und schock |